Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 58-63 , March 2007

Chemical Ablation of Liver Cancer

  • Timothy W.I. Clark, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Timothy W.I. Clark, MD, Associate Professor of Radiology, Chief, Vascular and Interventional Radiology, New York University School of Medicine, Suite HE-221, 560 First Avenue, New York, NY 10016.

References 

  1. Livraghi T, Festi D, Monti F, et al. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology. 1986;161:309–312
  2. Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy of hepatocellular carcinoma: Analysis of 77 patients. AJR Am J Roentgenol. 1990;155:1221–1226
  3. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology. 1995;197:101–108
  4. Lee MJ, Mueller PR, Dawson SL, et al. Percutaneous ethanol injection for the treatment of hepatic tumors: Indications, mechanism of action, technique, and efficacy. AJR Am J Roentgenol. 1995;164:215–220
  5. Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer. 1991;68:1524–1530
  6. Ishii H, Okada S, Nose H, et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer. 1996;77:1792–1796
  7. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: A study on 207 patients. Cancer. 1992;69:925–929
  8. Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol. 1997;32:1168–1173
  9. de Sio I, Castellano L, Calandra M. Hemobilia following percutaneous ethanol injection for hepatocellular carcinoma in a cirrhotic patient. J Clin Ultrasound. 1992;20:621–623
  10. Ohmoto K, Kunieda T, Shibata N, et al. Intraperitoneal hemorrhage as a major complication of percutaneous ethanol injection therapy for hepatocellular carcinoma. Hepatogastroenterology. 2000;47:1199–1202
  11. Redvanly RD, Chezmar JL, Strauss RM, et al. Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy. Radiology. 1993;188:283–285
  12. Ho CS, Kachura JR, Gallinger S, et al. Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: Efficacy and safety. Cardiovasc Intervent Radiol. 2007;30:241–247
  13. Shiina S, Hata Y, Niwa Y, et al. Multiple-needle insertion method in percutaneous ethanol injection therapy for liver neoplasms. Gastroenterol Jpn. 1991;26:47–50
  14. Obi S, Shiratori Y, Shiina S, et al. Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2000;12:285–290
  15. Livraghi T, Lazzaroni S, Pellicano S, et al. Percutaneous ethanol injection of hepatic tumors: Single-session therapy with general anesthesia. AJR Am J Roentgenol. 1993;161:1065–1069
  16. Livraghi T, Benedini V, Lazzaroni S, et al. Long-term results of single-session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer. 1998;83:48–57
  17. Giorgio A, Tarantino L, Francica G, et al. One-shot percutaneous ethanol injection of liver tumors under general anesthesia: Preliminary data on efficacy and complications. Cardiovasc Intervent Radiol. 1996;19:27–31
  18. Giorgio A, Tarantino L, de Stefano G, et al. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: Long-term results in 268 patients. Eur J Ultrasound. 2000;12:145–154
  19. Lencioni R, Cioni D, Uliana M, et al. Fatal thrombosis of the portal vein following single-session percutaneous ethanol injection therapy of hepatocellular carcinoma. Abdom Imaging. 1998;23:608–610
  20. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: Use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology. 1995;194:113–118
  21. Spiezia S, Vallone P, Fiore F, et al. Power Doppler sonography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma. Ital J Gastroenterol Hepatol. 1997;29:548–553
  22. Koito K, Namieno T, Ichimura T, et al. Power Doppler sonography: Evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy. AJR Am J Roentgenol. 2000;174:337–341
  23. Sato S, Shiratori Y, Imamura M, et al. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: A prospective study using 199 consecutive patients. J Hepatol. 2001;35:225–234
  24. Bartolozzi C, Lencioni R, Ricci P, et al. Hepatocellular carcinoma treatment with percutaneous ethanol injection: Evaluation with contrast-enhanced color Doppler US. Radiology. 1998;209:387–393
  25. Fiore F, Vallone P, Ricchi P, et al. Levovist-enhanced Doppler sonography versus spiral computed tomography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma. J Clin Gastroenterol. 2000;31:164–168
  26. Ding H, Kudo M, Onda H, et al. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: Comparison with dynamic CT. Radiology. 2001;221:721–730
  27. Bartolozzi C, Lencioni R, Caramella D, et al. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology. 1994;191:123–128
  28. Catalano O, Cusati B, Sandomenico F, et al. Helical CT findings in patients with hepatocellular carcinoma treated with percutaneous ablation procedures. J Comput Assist Tomogr. 2000;24:748–754
  29. Joseph FB, Baumgarten DA, Bernardino ME. Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy—work in progress. Radiology. 1993;186:553–556
  30. Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol. 2000;32:269–278
  31. Castellano L, Calandra M, Del Vecchio Blanco C, et al. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: Analysis of 71 patients. J Hepatol. 1997;27:862–870
  32. Koda M, Murawaki Y, Mitsuda A, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer. 2000;88:529–537
  33. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 1993;18:1121–1126
  34. Kotoh K, Sakai H, Sakamoto S, et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol. 1994;89:194–198
  35. Lencioni R, Pinto F, Armillotta N, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience. Eur Radiol. 1997;7:514–519
  36. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology. 2001;34:707–713
  37. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655–661
  38. Caturelli E. Percutaneous ablative therapies for small hepatocellular carcinoma: Radio-frequency or percutaneous ethanol injection?. Radiology. 2000;216:304–306
  39. Ohnishi K, Nomura F, Ito S, et al. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: Study of 91 cases. Hepatology. 1996;23:994–1002
  40. Ohnishi K, Yoshioka H, Ito S, et al. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology. 1998;27:67–72
  41. Van Hoof M, Joris JP, Horsmans Y, et al. Acute renal failure requiring haemodialysis after high-dose percutaneous acetic acid injection for hepatocellular carcinoma. Acta Gastroenterol Belg. 1999;62:49–51
  42. Tanaka K, Okazaki H, Nakamura S, et al. Hepatocellular carcinoma: Treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology. 1991;179:713–717
  43. Tanaka K, Nakamura S, Numata K, et al. The long-term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer. 1998;82:78–85
  44. Dohmen K, Shirahama M, Shigematsu H, et al. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: An evaluation of the local therapeutic effect and survival rate. Hepatogastroenterology. 2001;48:1409–1415
  45. Bartolozzi C, Lencioni R, Caramella D, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology. 1995;197:812–818
  46. Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized control study. Cancer. 2001;92:1516–1524

PII: S1089-2516(07)00074-1

doi: 10.1053/j.tvir.2007.08.004

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 58-63 , March 2007

Article Tools

* Image Usage & Resolution